Loading
 Jordan Ashley Fields

Jordan Ashley Fields

กลุ่มวิชาภาษาต่างประเทศ,
Faculty of Humanities and Social Sciences,
Khon Kaen University

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Basic design and equipment needed for a Coronary Care Unit. Shachtman, J
Fields, J
Craig, S
0
2. Family decision-making to withdraw life-sustaining treatments from hospitalized patients. Tilden, VP
Tolle, SW
Nelson, CA
Fields, J
0
3. An isolated human voluntary muscle preparation. DILLON, J
FIELDS, J
GUMAS, T
JENDEN, DJ
TAYLOR, DB
1955
4. Effect of the cardiac arrhythmias on the coronary circulation. CORDAY, E
GOLD, H
DE VERA, LB
WILLIAMS, JH
FIELDS, J
1959
5. Repair of ruptured interventricular septum complicating acute myocardial infarction. SHICKMAN, MD
FIELDS, J
PEARCE, ML
1959
6. Synthetic polyelectrolytes as tumour inhibitors. REGELSON, W
KUHAR, S
TUNIS, M
FIELDS, J
JOHNSON, J
GLUESENKAMP, E
1960
7. Cardiac resuscitation in coronary artery disease. A central coronary care unit. WILBURNE, M
FIELDS, J
1963
8. Histoplasma ulcer of the tongue. Hiley, P
Heilbrunn, C
Fields, J
1967
9. Emergency bypass surgery in impending and complicated acute myocardial infarction. Sustaita, H
Chatterjee, K
Matloff, JM
Marty, AT
Swan, HJ
Fields, J
1972
10. Surgical experience with temporary and permanent A-V sequential demand pacing. Fields, J
Berkovits, BV
Matloff, JM
1973
11. Recurrent reciprocating tachycardias in the Wolff-Parkinson-White syndrome; control by the use of a scanning pacemaker. Mandel, WJ
Laks, MM
Yamaguchi, I
Fields, J
Berkovits, B
1976
12. A prepaid pharmacy service in a student health center. Fields, J
Oppenheimer, T
1977
13. Carotid sinus syncope induced by malignant tumors in the neck. Emergence of vasodepressor manifestations following pacemaker therapy. Patel, AK
Yap, VU
Fields, J
Thomsen, JH
1979
14. Is faecal alpha 1-antitrypsin excretion a reliable screening test for protein-losing enteropathy? Haeney, MR
Fields, J
Carter, RA
Thompson, RA
Asquith, P
1979
15. Surgical aspects of inguinal lymphogranuloma venereum. Najafi, JA
Guzman, LG
Fields, J
1979
16. Development of the catecholamine innervation of the supraoptic nucleus in the Brattleboro rat. Sladek, JR
Fields, J
Phelps, CJ
Khachaturian, H
1984
17. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia. Koller, W
Curtin, J
Fields, J
1984
18. Simultaneous catecholamine histofluorescence and thymidine autoradiography of the sexually dimorphic nucleus of the preoptic area in the rat. Jacobson, CD
Adam, DE
Fields, J
Sladek, JR
1989
19. Two enteric coated microspheres in cystic fibrosis. Williams, J
MacDonald, A
Weller, PH
Fields, J
Pandov, H
1990
20. Indole-N-methylation of beta-carbolines: the brain's bioactivation route to toxins in Parkinson's disease? Collins, MA
Neafsey, EJ
Matsubara, K
Cobuzzi, R
Albores, R
Fields, J
Rollema, H
1992
21. Direct in vivo evaluation of pulmonary arterial pathology in chronic congestive heart failure with catheter-based intravascular ultrasound imaging. Porter, TR
Taylor, DO
Fields, J
Cycan, A
Akosah, K
Mohanty, PK
Pandian, NG
1993
22. Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension. Porter, TR
Taylor, DO
Cycan, A
Fields, J
Bagley, CW
Pandian, NG
Mohanty, PK
1993
23. Acute ethanol inhibits calcium influxes into esophageal smooth but not striated muscle: a possible mechanism for ethanol-induced inhibition of esophageal contractility. Keshavarzian, A
Zorub, O
Sayeed, M
Urban, G
Sweeney, C
Winship, D
Fields, J
1994
24. Evaluating teaching effectiveness. Kirschling, JM
Fields, J
Imle, M
Mowery, M
Tanner, CA
Perrin, N
Stewart, BJ
1995
25. A comparison of ultrasound and plain radiography in the diagnosis of maxillary sinusitis. Dobson, MJ
Fields, J
Woodford, T
1996
26. Ethanol at pharmacologically relevant concentrations inhibits contractility of isolated smooth muscle cells of cat esophagus. Keshavarzian, A
Muska, B
Sundaresan, R
Urban, G
Fields, J
1996
27. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. Schultz, C
Scott, C
Sherman, W
Donahue, B
Fields, J
Murray, K
Fisher, B
Abrams, R
Meis-Kindblom, J
1996
28. Amiodarone induced pulmonary fibrosis in infancy. Bowers, PN
Fields, J
Schwartz, D
Rosenfeld, LE
Nehgme, R
1998
29. The Prenatal Psychosocial Profile: a research and clinical tool. Curry, MA
Burton, D
Fields, J
1998
30. Risks of fatal injuries to farm workers 55-years of age and older. Myers, JR
Hard, DL
Snyder, KA
Casini, VJ
Cianfrocco, R
Fields, J
Morton, L
1999
31. The adjacent flanking region plays a critical role in facilitating the presentation of the Listeria monocytogenes product lemA to H2 M3wt-restricted, peptide-specific murine CD8 cells. Kurlander, RJ
Chao, E
Fields, J
Nataraj, C
1999
32. Young workers at risk when working in agricultural production. Hard, D
Myers, J
Snyder, K
Casini, V
Morton, L
Cianfrocco, R
Fields, J
1999
33. Alcohol: "ice-breaker" yes, "gut barrier-breaker," maybe. Keshavarzian, A
Fields, J
2000
34. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. Merke, DP
Keil, MF
Jones, JV
Fields, J
Hill, S
Cutler, GB
2000
35. Irritable bowel syndrome: an update on therapeutic modalities. Farhadi, A
Bruninga, K
Fields, J
Keshavarzian, A
2001
36. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. McDade, E
Boeve, BF
Burrus, TM
Boot, BP
Kantarci, K
Fields, J
Lowe, VJ
Peller, P
Knopman, D
Baker, M
Finch, N
Rademakers, R
Petersen, R
2012
37. Neuron mitochondria dynamics during HIV infection: Exploits of HIV-tat and gp120 in neuronal mitophagy and mitochondria biogenesis J. Fields
E. Masliah
2014
38. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. J. W. Murrough
K. A. Collins
J. Fields
K. E. DeWilde
M. L. Phillips
S. J. Mathew
E. Wong
C. Y. Tang
D. S. Charney
D. V. Iosifescu
2015
39. Absence of differences on key measures in mildly (CDR=0.5) versus overtly (CDR >= 1) symptomatic mutation carriers: preliminary data from LEFFTDS D. Knopman
B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
E. Huey
R. Hsiung
D. Irwin
K. Kantarci
A. Karydas
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
S. Weintraub
Z. Wszolek
A. Vetor
2016
40. Characteristics and Progress on the Initial 147 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016
41. Characteristics and progress on the Initial 256 participants in the advancing research and treatment in frontotemporal lobar degeneration (ARTFL) North American Rare disease clinical research consortium A. Boxer
H. Rosen
B. Boeve
H. Heuer
S. Laxineta
M. Grossman
G. Coppola
B. Dickerson
Y. Bordelon
R. Conwit
C. Dheel
K. Faber
H. Feldman
J. Ferguson
J. Fields
J. Fong
T. Foroud
W. Galpern
N. Ghoshal
N. Graff-Radford
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
D. Kaufer
A. Karydas
A. Klein
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Litvan
I. Mackenzie
M. Mendez
B. Miller
M. Miller
C. Onyike
A. Pantelyat
R. Rademakers
E. Roberson
M. Sutherland
M. C. Tartaglia
N. Tatton
A. Toga
A. Vetor
S. Weintraub
Z. Wszolek
2016
42. Differences on clinical measures in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS D. Knopman
B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016
43. Differences on neuropsychiatric measures in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS H. Rosen
B. Boeve
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Faroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
G. -Y. R. Hsiung
E. D. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016
44. Differences on neuropsychological measures in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS J. Kramer
S. Weintraub
B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Faroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
Z. Wszolek
2016
45. Differences on novel measures of social comportment in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS K. Rankin
J. Kramer
H. Rosen
B. Boeve
A. Boxer
G. Coppola
B. Dickerson
C. Dheel
J. Fields
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
J. Kornak
D. Knopman
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016
46. Evolution from the asymptomatic to symptomatic state in familial FTD: longitudinal neuropsychological and MRI findings in three MAPT mutation carriers C. Dheel
S. Przybelski
M. Senjem
K. Kantarci
D. Jones
J. Fields
M. Machulda
C. Jack
R. Rademakers
D. Knopman
Z. Wszolek
R. Petersen
B. Boeve
2016
47. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. P. H. Lizotte
A. M. Wen
M. R. Sheen
J. Fields
P. Rojanasopondist
N. F. Steinmetz
S. Fiering
2016
48. NIH EXAMINER as tool for tracking executive dysfunction in carriers of FTLD-causing mutations within the LEFFTDS Consortium H. Rosen
P. Ljubenkov
B. Boeve
J. Kramer
A. Boxer
G. Coppola
C. Dheel
J. Fields
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
G. -Y. R. Hsiung
E. D. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
W. Kukull
I. Mackensie
B. Miller
C. Phelps
R. Rademakers
L. Shaw
M. Sutherland
A. Toga
S. Weintraub
Z. Wszolek
T. Faroud
K. Faber
A. Vetor
J. Trojanowski
K. Rankin
2016
49. Similar findings on clinical and neuropsychological measures in asymptomatic mutation versus non-mutation carriers: preliminary data from LEFFTDS B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016
50. Ratio of dietary rumen degradable protein to rumen undegradable protein affects nitrogen partitioning but does not affect the bovine milk proteome produced by mid-lactation Holstein dairy cows. Tacoma, R
Fields, J
Ebenstein, DB
Lam, YW
Greenwood, SL
2017
51. Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration. Casaletto, KB
Staffaroni, AM
Wolf, A
Appleby, B
Brushaber, D
Coppola, G
Dickerson, B
Domoto-Reilly, K
Elahi, FM
Fields, J
Fong, JC
Forsberg, L
Ghoshal, N
Graff-Radford, N
Grossman, M
Heuer, HW
Hsiung, GY
Huey, ED
Irwin, D
Kantarci, K
Kaufer, D
Kerwin, D
Knopman, D
Kornak, J
Kramer, JH
Litvan, I
Mackenzie, IR
Mendez, M
Miller, B
Rademakers, R
Ramos, EM
Rascovsky, K
Roberson, ED
Syrjanen, JA
Tartaglia, MC
Weintraub, S
Boeve, B
Boxer, AL
Rosen, H
Yaffe, K
,
2020
52. Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Heuer, HW
Wang, P
Rascovsky, K
Wolf, A
Appleby, B
Bove, J
Bordelon, Y
Brannelly, P
Brushaber, DE
Caso, C
Coppola, G
Dickerson, B
Dickinson, S
Domoto-Reilly, K
Faber, K
Ferrall, J
Fields, J
Fishman, A
Fong, J
Foroud, T
Forsberg, LK
Gearhart, D
Ghazanfari, B
Ghoshal, N
Goldman, J
Graff-Radford, J
Graff-Radford, N
Grant, I
Grossman, M
Haley, D
Hsiung, GY
Huey, E
Irwin, D
Jones, D
Kantarci, K
Karydas, A
Kaufer, D
Kerwin, D
Knopman, D
Kornak, J
Kramer, JH
Kraft, R
Kremers, WK
Kukull, W
Litvan, I
Ljubenkov, P
Mackenzie, IR
Maldonado, M
Manoochehri, M
McGinnis, S
McKinley, E
Mendez, MF
Miller, BL
Onyike, C
Pantelyat, A
Pearlman, R
Petrucelli, L
Potter, M
Rademakers, R
Ramos, EM
Rankin, KP
Roberson, ED
Rogalski, E
Sengdy, P
Shaw, L
Syrjanen, J
Tartaglia, MC
Tatton, N
Taylor, J
Toga, A
Trojanowski, J
Weintraub, S
Wong, B
Wszolek, Z
Boeve, BF
Rosen, HJ
Boxer, AL
,
2020
Count 0 41 13 0

Title Authors Year Publication name Cited count
< 2017 2018 2019 2020 2021 2022 Total

Title Authors Year Journal title
1. An isolated human voluntary muscle preparation. DILLON, J
FIELDS, J
GUMAS, T
JENDEN, DJ
TAYLOR, DB
1955 Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
2 (90), pp. 409
2. Repair of ruptured interventricular septum complicating acute myocardial infarction. SHICKMAN, MD
FIELDS, J
PEARCE, ML
1959 A.M.A. archives of internal medicine
1 (103), pp. 140-5
3. Effect of the cardiac arrhythmias on the coronary circulation. CORDAY, E
GOLD, H
DE VERA, LB
WILLIAMS, JH
FIELDS, J
1959 Annals of internal medicine
3 (50), pp. 535-53
4. Synthetic polyelectrolytes as tumour inhibitors. REGELSON, W
KUHAR, S
TUNIS, M
FIELDS, J
JOHNSON, J
GLUESENKAMP, E
1960 Nature
(186), pp. 778-80
5. Cardiac resuscitation in coronary artery disease. A central coronary care unit. WILBURNE, M
FIELDS, J
1963 JAMA
(184), pp. 453-7
6. Histoplasma ulcer of the tongue. Hiley, P
Heilbrunn, C
Fields, J
1967 JAMA
12 (200), pp. 1130-1
7. Emergency bypass surgery in impending and complicated acute myocardial infarction. Sustaita, H
Chatterjee, K
Matloff, JM
Marty, AT
Swan, HJ
Fields, J
1972 Archives of surgery (Chicago, Ill. : 1960)
1 (105), pp. 30-5
8. Surgical experience with temporary and permanent A-V sequential demand pacing. Fields, J
Berkovits, BV
Matloff, JM
1973 The Journal of thoracic and cardiovascular surgery
6 (66), pp. 865-77
9. Recurrent reciprocating tachycardias in the Wolff-Parkinson-White syndrome; control by the use of a scanning pacemaker. Mandel, WJ
Laks, MM
Yamaguchi, I
Fields, J
Berkovits, B
1976 Chest
6 (69), pp. 769-74
10. A prepaid pharmacy service in a student health center. Fields, J
Oppenheimer, T
1977 Journal of the American Pharmaceutical Association
6 (17), pp. 350-3
11. Carotid sinus syncope induced by malignant tumors in the neck. Emergence of vasodepressor manifestations following pacemaker therapy. Patel, AK
Yap, VU
Fields, J
Thomsen, JH
1979 Archives of internal medicine
11 (139), pp. 1281-4
12. Is faecal alpha 1-antitrypsin excretion a reliable screening test for protein-losing enteropathy? Haeney, MR
Fields, J
Carter, RA
Thompson, RA
Asquith, P
1979 Lancet (London, England)
8153 (2), pp. 1161-2
13. Surgical aspects of inguinal lymphogranuloma venereum. Najafi, JA
Guzman, LG
Fields, J
1979 Military medicine
10 (144), pp. 697-9
14. Development of the catecholamine innervation of the supraoptic nucleus in the Brattleboro rat. Sladek, JR
Fields, J
Phelps, CJ
Khachaturian, H
1984 Peptides
(5), pp. 151-5
15. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia. Koller, W
Curtin, J
Fields, J
1984 Neuropharmacology
10 (23), pp. 1191-4
16. Simultaneous catecholamine histofluorescence and thymidine autoradiography of the sexually dimorphic nucleus of the preoptic area in the rat. Jacobson, CD
Adam, DE
Fields, J
Sladek, JR
1989 Experimental neurology
3 (104), pp. 257-63
17. Two enteric coated microspheres in cystic fibrosis. Williams, J
MacDonald, A
Weller, PH
Fields, J
Pandov, H
1990 Archives of disease in childhood
6 (65), pp. 594-7
18. Indole-N-methylation of beta-carbolines: the brain's bioactivation route to toxins in Parkinson's disease? Collins, MA
Neafsey, EJ
Matsubara, K
Cobuzzi, R
Albores, R
Fields, J
Rollema, H
1992 Annals of the New York Academy of Sciences
(648), pp. 263-5
19. Direct in vivo evaluation of pulmonary arterial pathology in chronic congestive heart failure with catheter-based intravascular ultrasound imaging. Porter, TR
Taylor, DO
Fields, J
Cycan, A
Akosah, K
Mohanty, PK
Pandian, NG
1993 The American journal of cardiology
8 (71), pp. 754-7
20. Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension. Porter, TR
Taylor, DO
Cycan, A
Fields, J
Bagley, CW
Pandian, NG
Mohanty, PK
1993 Journal of the American College of Cardiology
5 (22), pp. 1418-24
21. Acute ethanol inhibits calcium influxes into esophageal smooth but not striated muscle: a possible mechanism for ethanol-induced inhibition of esophageal contractility. Keshavarzian, A
Zorub, O
Sayeed, M
Urban, G
Sweeney, C
Winship, D
Fields, J
1994 The Journal of pharmacology and experimental therapeutics
3 (270), pp. 1057-62
22. Evaluating teaching effectiveness. Kirschling, JM
Fields, J
Imle, M
Mowery, M
Tanner, CA
Perrin, N
Stewart, BJ
1995 The Journal of nursing education
9 (34), pp. 401-10
23. Ethanol at pharmacologically relevant concentrations inhibits contractility of isolated smooth muscle cells of cat esophagus. Keshavarzian, A
Muska, B
Sundaresan, R
Urban, G
Fields, J
1996 Alcoholism, clinical and experimental research
1 (20), pp. 180-4
24. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. Schultz, C
Scott, C
Sherman, W
Donahue, B
Fields, J
Murray, K
Fisher, B
Abrams, R
Meis-Kindblom, J
1996 Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2 (14), pp. 556-64
25. A comparison of ultrasound and plain radiography in the diagnosis of maxillary sinusitis. Dobson, MJ
Fields, J
Woodford, T
1996 Clinical radiology
3 (51), pp. 170-2
26. Amiodarone induced pulmonary fibrosis in infancy. Bowers, PN
Fields, J
Schwartz, D
Rosenfeld, LE
Nehgme, R
1998 Pacing and clinical electrophysiology : PACE
8 (21), pp. 1665-7
27. The Prenatal Psychosocial Profile: a research and clinical tool. Curry, MA
Burton, D
Fields, J
1998 Research in nursing & health
3 (21), pp. 211-9
28. Young workers at risk when working in agricultural production. Hard, D
Myers, J
Snyder, K
Casini, V
Morton, L
Cianfrocco, R
Fields, J
1999 American journal of industrial medicine
(0), pp. 31-3
29. The adjacent flanking region plays a critical role in facilitating the presentation of the Listeria monocytogenes product lemA to H2 M3wt-restricted, peptide-specific murine CD8 cells. Kurlander, RJ
Chao, E
Fields, J
Nataraj, C
1999 Journal of immunology (Baltimore, Md. : 1950)
12 (163), pp. 6741-7
30. Risks of fatal injuries to farm workers 55-years of age and older. Myers, JR
Hard, DL
Snyder, KA
Casini, VJ
Cianfrocco, R
Fields, J
Morton, L
1999 American journal of industrial medicine
(0), pp. 29-30
31. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. Merke, DP
Keil, MF
Jones, JV
Fields, J
Hill, S
Cutler, GB
2000 The Journal of clinical endocrinology and metabolism
3 (85), pp. 1114-20
32. Alcohol: "ice-breaker" yes, "gut barrier-breaker," maybe. Keshavarzian, A
Fields, J
2000 The American journal of gastroenterology
5 (95), pp. 1124-5
33. Irritable bowel syndrome: an update on therapeutic modalities. Farhadi, A
Bruninga, K
Fields, J
Keshavarzian, A
2001 Expert opinion on investigational drugs
7 (10), pp. 1211-22
34. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. McDade, E
Boeve, BF
Burrus, TM
Boot, BP
Kantarci, K
Fields, J
Lowe, VJ
Peller, P
Knopman, D
Baker, M
Finch, N
Rademakers, R
Petersen, R
2012 Neurology
16 (78), pp. 1245-9
35. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Murrough, JW
Collins, KA
Fields, J
DeWilde, KE
Phillips, ML
Mathew, SJ
Wong, E
Tang, CY
Charney, DS
Iosifescu, DV
2015 Translational psychiatry
(5), pp. e509
36. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer. Lizotte, PH
Wen, AM
Sheen, MR
Fields, J
Rojanasopondist, P
Steinmetz, NF
Fiering, S
2016 Nature nanotechnology
3 (11), pp. 295-303
37. Ratio of dietary rumen degradable protein to rumen undegradable protein affects nitrogen partitioning but does not affect the bovine milk proteome produced by mid-lactation Holstein dairy cows. Tacoma, R
Fields, J
Ebenstein, DB
Lam, YW
Greenwood, SL
2017 Journal of dairy science
9 (100), pp. 7246-7261
38. Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Heuer, HW
Wang, P
Rascovsky, K
Wolf, A
Appleby, B
Bove, J
Bordelon, Y
Brannelly, P
Brushaber, DE
Caso, C
Coppola, G
Dickerson, B
Dickinson, S
Domoto-Reilly, K
Faber, K
Ferrall, J
Fields, J
Fishman, A
Fong, J
Foroud, T
Forsberg, LK
Gearhart, D
Ghazanfari, B
Ghoshal, N
Goldman, J
Graff-Radford, J
Graff-Radford, N
Grant, I
Grossman, M
Haley, D
Hsiung, GY
Huey, E
Irwin, D
Jones, D
Kantarci, K
Karydas, A
Kaufer, D
Kerwin, D
Knopman, D
Kornak, J
Kramer, JH
Kraft, R
Kremers, WK
Kukull, W
Litvan, I
Ljubenkov, P
Mackenzie, IR
Maldonado, M
Manoochehri, M
McGinnis, S
McKinley, E
Mendez, MF
Miller, BL
Onyike, C
Pantelyat, A
Pearlman, R
Petrucelli, L
Potter, M
Rademakers, R
Ramos, EM
Rankin, KP
Roberson, ED
Rogalski, E
Sengdy, P
Shaw, L
Syrjanen, J
Tartaglia, MC
Tatton, N
Taylor, J
Toga, A
Trojanowski, J
Weintraub, S
Wong, B
Wszolek, Z
Boeve, BF
Rosen, HJ
Boxer, AL
,
2020 Alzheimer's & dementia : the journal of the Alzheimer's Association
1 (16), pp. 60-70
39. Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration. Casaletto, KB
Staffaroni, AM
Wolf, A
Appleby, B
Brushaber, D
Coppola, G
Dickerson, B
Domoto-Reilly, K
Elahi, FM
Fields, J
Fong, JC
Forsberg, L
Ghoshal, N
Graff-Radford, N
Grossman, M
Heuer, HW
Hsiung, GY
Huey, ED
Irwin, D
Kantarci, K
Kaufer, D
Kerwin, D
Knopman, D
Kornak, J
Kramer, JH
Litvan, I
Mackenzie, IR
Mendez, M
Miller, B
Rademakers, R
Ramos, EM
Rascovsky, K
Roberson, ED
Syrjanen, JA
Tartaglia, MC
Weintraub, S
Boeve, B
Boxer, AL
Rosen, H
Yaffe, K
,
2020 Alzheimer's & dementia : the journal of the Alzheimer's Association
1 (16), pp. 91-105
40. Family decision-making to withdraw life-sustaining treatments from hospitalized patients. Tilden, VP
Tolle, SW
Nelson, CA
Fields, J
Nursing research
2 (50), pp. 105-15
41. Basic design and equipment needed for a Coronary Care Unit. Shachtman, J
Fields, J
Craig, S
Israel journal of medical sciences
2 (3), pp. 287-94

Title Authors Year Journal title Cited count
< 2017 2018 2019 2020 2021 2022 Total
1. Neuron mitochondria dynamics during HIV infection: Exploits of HIV-tat and gp120 in neuronal mitophagy and mitochondria biogenesis J. Fields
E. Masliah
2014 JOURNAL OF NEUROIMMUNE PHARMACOLOGY
1.0 (9.0), pp. 17.0-18.0
0 0 0 0 0 0 0
2. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder J. W. Murrough
K. A. Collins
J. Fields
K. E. DeWilde
M. L. Phillips
S. J. Mathew
E. Wong
C. Y. Tang
D. S. Charney
D. V. Iosifescu
2015 TRANSLATIONAL PSYCHIATRY
(5.0), pp.
10 0 0 0 0 0 10
3. Absence of differences on key measures in mildly (CDR=0.5) versus overtly (CDR >= 1) symptomatic mutation carriers: preliminary data from LEFFTDS D. Knopman
B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
E. Huey
R. Hsiung
D. Irwin
K. Kantarci
A. Karydas
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
S. Weintraub
Z. Wszolek
A. Vetor
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 316.0-316.0
0 0 0 0 0 0 0
4. Characteristics and Progress on the Initial 147 Subjects in the Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Protocol B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 309.0-309.0
0 0 0 0 0 0 0
5. Characteristics and progress on the Initial 256 participants in the advancing research and treatment in frontotemporal lobar degeneration (ARTFL) North American Rare disease clinical research consortium A. Boxer
H. Rosen
B. Boeve
H. Heuer
S. Laxineta
M. Grossman
G. Coppola
B. Dickerson
Y. Bordelon
R. Conwit
C. Dheel
K. Faber
H. Feldman
J. Ferguson
J. Fields
J. Fong
T. Foroud
W. Galpern
N. Ghoshal
N. Graff-Radford
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
D. Kaufer
A. Karydas
A. Klein
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Litvan
I. Mackenzie
M. Mendez
B. Miller
M. Miller
C. Onyike
A. Pantelyat
R. Rademakers
E. Roberson
M. Sutherland
M. C. Tartaglia
N. Tatton
A. Toga
A. Vetor
S. Weintraub
Z. Wszolek
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 379.0-379.0
0 0 0 0 0 0 0
6. Differences on clinical measures in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS D. Knopman
B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 317.0-317.0
0 0 0 0 0 0 0
7. Differences on neuropsychiatric measures in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS H. Rosen
B. Boeve
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Faroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
G. -Y. R. Hsiung
E. D. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 287.0-287.0
0 0 0 0 0 0 0
8. Differences on neuropsychological measures in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS J. Kramer
S. Weintraub
B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Faroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
Z. Wszolek
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 290.0-291.0
0 0 0 0 0 0 0
9. Differences on novel measures of social comportment in asymptomatic (CDR=0) versus mildly symptomatic (CDR=0.5) mutation carriers: preliminary data from LEFFTDS K. Rankin
J. Kramer
H. Rosen
B. Boeve
A. Boxer
G. Coppola
B. Dickerson
C. Dheel
J. Fields
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
J. Kornak
D. Knopman
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 299.0-299.0
0 0 0 0 0 0 0
10. Evolution from the asymptomatic to symptomatic state in familial FTD: longitudinal neuropsychological and MRI findings in three MAPT mutation carriers C. Dheel
S. Przybelski
M. Senjem
K. Kantarci
D. Jones
J. Fields
M. Machulda
C. Jack
R. Rademakers
D. Knopman
Z. Wszolek
R. Petersen
B. Boeve
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 403.0-403.0
0 0 0 0 0 0 0
11. In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer P. H. Lizotte
A. M. Wen
M. R. Sheen
J. Fields
P. Rojanasopondist
N. F. Steinmetz
S. Fiering
2016 NATURE NANOTECHNOLOGY
3.0 (11.0), pp. 295.0-+
20 0 0 0 0 0 20
12. NIH EXAMINER as tool for tracking executive dysfunction in carriers of FTLD-causing mutations within the LEFFTDS Consortium H. Rosen
P. Ljubenkov
B. Boeve
J. Kramer
A. Boxer
G. Coppola
C. Dheel
J. Fields
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
G. -Y. R. Hsiung
E. D. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
W. Kukull
I. Mackensie
B. Miller
C. Phelps
R. Rademakers
L. Shaw
M. Sutherland
A. Toga
S. Weintraub
Z. Wszolek
T. Faroud
K. Faber
A. Vetor
J. Trojanowski
K. Rankin
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 314.0-314.0
0 0 0 0 0 0 0
13. Similar findings on clinical and neuropsychological measures in asymptomatic mutation versus non-mutation carriers: preliminary data from LEFFTDS B. Boeve
H. Rosen
A. Boxer
G. Coppola
C. Dheel
B. Dickerson
K. Faber
J. Fields
T. Foroud
R. Gavrilova
N. Ghoshal
J. Goldman
N. Graff-Radford
M. Grossman
H. Heuer
J. Hsiao
R. Hsiung
E. Huey
D. Irwin
K. Kantarci
A. Karydas
D. Knopman
J. Kornak
J. Kramer
W. Kukull
I. Mackenzie
B. Miller
C. Phelps
R. Rademakers
K. Rankin
L. Shaw
M. Sutherland
A. Toga
J. Trojanowski
A. Vetor
S. Weintraub
Z. Wszolek
2016 JOURNAL OF NEUROCHEMISTRY
(138.0), pp. 287.0-287.0
0 0 0 0 0 0 0

Title Authors Year Journal title

Title Authors NRIIS type Year NRIIS Scholarship

0.03992652893066406